SINCLAIR PHARMA PLC
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 43.07B | ||||||
| 21.51B | ||||||
| 15.19B | ||||||
| 14.44B | ||||||
| 13.12B |
